Positron Emission Tomography Imaging of Neuroinflammation

Neurotherapeutics

Volumn 4, Issue 3, 2007, Pages 443-452

  Cagnin, Annachiara ^a,b   Kassiou, Michael ^c,d   Meikle, Steve R ^c   Banati, Richard B ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

brain; microglia; neuroinflammation; PBR; Peripheral benzodiazepine receptor; PET; PK11195

Indexed keywords

BENZODIAZEPINE RECEPTOR; FLUORODEOXYGLUCOSE F 18; FLUORODOPA F 18; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG; VINPOCETINE C 11;

ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; BRAIN DISEASE; BRAIN REGION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DEMENTIA; ENCEPHALITIS; HEPATIC ENCEPHALOPATHY; HUMAN; ISOTOPE LABELING; METABOLIC ENCEPHALOPATHY; MICROGLIA; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PERIPHERAL NERVE INJURY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASMUSSEN SYNDROME;

ANIMALS; BRAIN; BRAIN DISEASES; CARBON RADIOISOTOPES; HUMANS; INFLAMMATION; ISOQUINOLINES; MICROGLIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, GABA;

EID: 34250696978     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.04.006     Document Type: Article

References (73)

1. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. TINS 19 (1996) 312-318
2. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005) 1314-1318
3. Davalos D., Grutzendler J., Jang G., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8 (2005) 752-758
4. Graeber M.B. Glial inflammation in neurodegenerative diseases. [abstract]. Immunology 101 Suppl 1 (2001) 52
5. Cagnin A., Taylor-Robinson S.D., Forton D.M., and Banati R.B. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 55 (2006) 547-553
6. Banati R.B., Cagnin A., Brooks D.J., et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 12 (2001) 3439-3442
7. Banati R.B. Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation?. J Physiol Paris 96 (2002) 289-299
8. Banati R.B., Gehrmann J., Schubert P., and Kreutzberg G.W. Cytotoxicity of microglia. Glia 7 (1993) 111-118
9. Banati R.B., and Graeber M.B. Surveillance, intervention and cytotoxicity: is there a protective role of microglia?. Dev Neurosci 16 (1994) 114-127
10. Raivich G., and Banati R. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 46 (2004) 261-281
11. Duke D.C., Moran L.B., Turkheimer F., Banati R.B., and Graeber M.B. Microglia in culture: what genes do they express?. Dev Neurosci 26 (2004) 30-37
12. Moran L.B., Duke D.C., Turkheimer F.E., Banati R.B., and Graeber M.B. Towards a transcriptome definition of microglial cells. Neurogenetics 5 (2004) 95-108
13. Banati R.B. Visualising microglial activation in vivo. Glia 40 (2002) 206-217
14. Hertz L. Binding characteristics of the receptor and coupling to transport proteins. In: Giessen-Crouse E. (Ed). Peripheral benzodiazepine receptors (1993), Academic Press, London 27-51
15. Anholt R.R., Pedersen P.L., De Souza E.B., and Snyder S.H. The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane. J Biol Chem 261 (1986) 576-583
16. Olson J.M., McNeel W., Young A.B., and Mancini W.R. Localization of the peripheral-type benzodiazepine binding site to mitochondria of human glioma cells. J Neurooncol 13 (1992) 35-42
17. Benavides J., Cornu P., Dennis T., et al. Imaging of human brain lesions with an omega-3 site radioligand. Ann Neurol 24 (1988) 708-712
18. 3H]PK 11195 binding in rat brain cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11 (1991) 314-332
19. 3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat. Neuroscience 82 (1998) 805-817
20. Itzhak Y., Baker L., and Norenberg M.D. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 9 (1993) 211-218
21. Banati R.B., Myers R., and Kreutzberg G.W. PK ('peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol 26 (1997) 77-82
22. Veenman L., Levin E., Weisinger G., et al. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem Pharmacol 68 (2004) 689-698
23. Lee D.H., Kang S.K., Lee R.H., et al. Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells. J Cell Physiol 198 (2004) 91-99
24. Gavish M., Bachman I., Shoukrun R., et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51 (1999) 629-650
25. Papadopoulos V., Baraldi M., and Guilarte T.R. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27 (2006) 402-409
26. 0-ATPase by ligands of the peripheral benzodiazepine receptor. Bioorg Med Chem Lett 17 (2007) 1667-1670
27. Banati R.B., Newcombe J., Gunn R.N., et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo-imaging of microglia as a measure of disease activity. Brain 123 (2000) 2321-2337
28. Stephenson D.T., Schober D.A., Smalstig E.B., Mincy R.C., Gehlert D.R., and Clemens J.A. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15 (1995) 5263-5274
29. Rao V.L., Dogan A., Bowen K.K., and Dempsey R.J. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol 16 (2000) 102-114
30. Kuhlmann A.C., and Guilarte T.R. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 4 (2000) 1694-1704
31. Chen M.K., Baidoo K., Verina T., and Guilarte T.R. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 127 (2004) 1379-1392
32. 11C](R)-PK11195 PET-imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 53 (1999) 2199-2203
33. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 4 (1996) 153-158
34. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6 (1997) 279-287
35. Ashburner J., Haslam J., Taylor C., Cunningham V., and Jones T. A cluster analysis approach for the characterization of dynamic PET data. In: Myers R., Cunningham V., Bailey D., and Jones T. (Eds). Quantification of brain function using PET (1996), Academic Press, San Diego 301-306
36. Acton P.D., Pilowsky L.S., Costa D.C., and Ell P.J. Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia. Eur J Nucl Med 2 (1997) 111-118
37. Gunn R.N., Lammertsma A.A., and Cunningham V.J. Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis. In: Carson R., Daule M., Witherspoon P., and Herscovitch P. (Eds). Quantitative functional brain imaging with positron emission tomography (1998), Academic Press, San Diego 401-406
38. 11C](R)-PK11195 PET. [Abstract]. J Cereb Blood Flow Metab 19 Suppl (1999) S789
39. 11C](R)-PK11195 PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124 (2001) 2014-2027
40. 11C](R)-PK11195 brain studies. J Nucl Med 48 (2007) 158-167
41. Rasmussen T., and Andermann F. Rasmussen's syndrome: symptomatology of the syndrome of chronic encephalitis and seizures: 35-year experience with 51 cases. In: Lüders H. (Ed). Epilepsy surgery. 1st ed. (1991), Raven Press, New York 173-182
42. Oguni H., Andermann F., and Rasmussen T.B. The syndrome of chronic encephalitis and epilepsy: a study based on the MNI series of 48 cases. Adv Neurol 57 (1992) 419-433
43. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21 (1995) 195-218
44. Ouchi Y., Yoshikawa E., Sekine Y., et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57 (2005) 168-175
45. 11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 21 (2006) 404-412
46. 11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61 (2003) 686-689
47. 11C](R)-PK11195 PET in progressive supranuclear palsy. Mov Disord 21 (2006) 89-93
48. 11C](R)-PK11195 PET in corticobasal degeneration. Mov Disord 19 (2004) 1221-1226
49. Imamura K., Hishikawa N., Sawada M., et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol (Berl) 106 (2003) 518-526
50. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
51. Sapp E., Kegel K.B., Aronin N., et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60 (2001) 161-172
52. Pavese N., Gerhard A., Tai Y.F., et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66 (2006) 1638-1643
53. Tai Y.F., Pavese N., Gerhard A., et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain (2007) Mar 30 [Epub ahead of print].
54. Veerhuis R., Hoozemans J.J.M., Cagnin A., Eikelemboom P., and Banati R.B. The activation of microglia as an early sign of disease progression in Alzheimer's disease. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia. 2nd ed. (2004), Oxford University Press, New York 1027-1043
55. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
56. Cagnin A., Brooks D.J., Kennedy A.M., et al. In-vivo measurement of activated microglia in dementia. Lancet 358 (2001) 461-467 Erratum in: Lancet 2001;358:766]
57. Schenk D., Barbour R., Dunn W., et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
58. Cagnin A., Rossor M., Sampson E.L., MacKinnon T., and Banati R.B. In vivo detection of microglia activation in frontotemporal dementia. Ann Neurol 56 (2004) 894-897
59. 11C](R)-PK11195 PET study. Neuroimage 24 (2005) 591-595
60. Price C.S., Wang D., and Menon D.K. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 37 (2006) 1749-1753
61. 11C]PK11195. Neurology 55 (2000) 1052-1054
62. Sobel R.A., Collins A.B., Colvin R.B., and Bhan A.K. The in situ cellular autoimmune response in acute herpes simplex encephalitis. Am J Pathol 125 (1986) 332-338
63. Esiri M.M., Drummond C.W., and Morris C.S. Macrophages and microglia in HSV-1 infected mouse brain. J Neuroimmunol 62 (1995) 201-205
64. Jones E.G. Cortical and subcortical contributions to activity-dependent plasticity in primate somatosensory cortex. Annu Rev Neurosci 23 (2000) 1-37
65. Kassiou M., Meikle S.R., and Banati R.B. Ligands for peripheral benzodiazepine binding sites in glial cells. Brain Res Brain Res Rev 48 (2005) 207-210
66. 11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 52 (2004) 283-291
67. 11C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol 30 (2003) 513-519
68. Zhang M.R., Maeda J., Ogawa M., et al. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl) acetamide, for PET imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem 22 (2004) 2228-2235
69. Fujimura Y., Ikoma Y., Yasuno F., et al. Quantitative analyses of 18 F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. J Nucl Med 47 (2006) 43-50
70. 11C]vinpocetine in human subjects. Acta Neurol Scand 106 (2002) 325-332
71. 11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. J Neurol Sci 15 (2005) 219-223
72. Belloli S., Moresco R.M., Matarrese M., et al. Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo PET imaging of neurodegeneration. Neurochem Int 44 (2004) 433-440
73. James M.L., Fulton R.R., Henderson D.J., et al. Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. Bioorg Med Chem 13 (2005) 6188-6194